FDA Clearance Tracker · DEN140030
SpaceOAR System
Last checked: Nov 20, 2026Latest source record: Apr 1, 2015 (this decision)Source: openFDAMethods & limitations
Decided
Apr 1, 2015
De Novo granted
Time to decision
182 days
Received Oct 1, 2014. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Direct
Device class
Class II
The decision
- FDA number
- DEN140030
- Device name
- SpaceOAR System
- Applicant
- Augmenix, Inc.
- Applicant location
- Waltham, MA
- Received
- Oct 1, 2014
- Decided
- Apr 1, 2015
- Decision
- De Novo granted
- Submission type
- Direct
Device type
- Device type
- Hydrogel Spacer (OVB)
- Device class
- Class II
- Regulation
- 21 CFR 892.5725
- Specialty
- Radiology & Imaging
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for DEN140030
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for Augmenix, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- SpaceOAR Vue Hydrogel510(k)
K182971 · Decided Jul 19, 2019 · 266 days after receipt
Device type: Hydrogel Spacer (OVB) · Radiology & Imaging
- SpaceOAR System510(k)
K181465 · Decided Jun 25, 2018 · 21 days after receipt
Device type: Hydrogel Spacer (OVB) · Radiology & Imaging
K151998 · Decided Aug 19, 2015 · 30 days after receipt
Device type: Marker, Radiographic, Implantable (NEU) · General & Plastic Surgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.